Jacqueline Elizabeth Shea, Chief Operating Officer at INOVIO PHARMACEUTICALS, INC. (INO), sold 11,957 shares at $8.97 ($108K) on 2021-03-26, disclosed to the SEC on 2021-03-26.
Scheduled sale ($108k) by Chief Operating Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.06 | 7,247 | $66K | 60.8% |
| 2 | $8.97 | 4,710 | $42K | 39.2% |
| Total | $9.02 avg | 11,957 | $108K | 100% |
| Filing → |
| INO | SELL | 2021-02-03 | $763K | — | Filing → |
| INO | SELL | 2021-01-29 | $1.1M | — | Filing → |